To help mitigate any potential provider reimbursement delays prior to permanent J-code assignment, up to 120-day extended payment terms for INLEXZO™ may be available from your Authorized Specialty Distributor. Actual payment terms are determined by your Authorized Specialty Distributor. Please reach out to your Authorized Specialty Distributor for more details.
Provides key instructions on ordering INLEXZO™.
How to order INLEXZO™ for your office through our specialty distributor network.
A helpful guide with general information on coverage and coding relevant to administering INLEXZO™.
A checklist to guide you through the prior authorization process.
A template that you can fill out to submit to a patient’s health insurance.
At Johnson & Johnson, we are committed to helping people in their fight against cancer. Our J&J withMe program is here at every step to provide personalized support to help patients start and stay on their J&J treatment.
Access Support—to help navigate payer processes.
Affordability Resources—to help patients discover ways to afford their INLEXZO™ treatment.
Dedicated, free 1-on-1 Care Navigator Support for Your Patients—offered through INLEXZO withMe to support the nonclinical needs that may arise while on INLEXZO™.
*J&J withMe cannot accept any patient information without an executed BAA or individual patient authorization. In addition, a benefits investigation must be submitted for each patient for whom treatment with a Johnson & Johnson medicine is requested.
†Healthcare professionals may request that patients not be called concerning insurance benefits investigation by requesting a limitation of services. However, patients may request these services by contacting J&J withMe.
‡We do not fill out any information that requires the medical judgment of the prescriber, and only the prescriber can determine whether to pursue a prior authorization.
The J&J withMe Savings Program can help eligible patients save on their out-of-pocket treatment costs. Your eligible patients will pay $5 per treatment for their INLEXZO™ out-of-pocket treatment costs and
$0 per treatment for certain treatment administration costs. Program provides two separate offerings: Treatment Cost Support for the cost of INLEXZO™ treatment and Treatment Administration Cost Support for costs related to each insertion and removal of the treatment delivery system. Maximum program benefit per calendar year shall apply. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their treatment. Terms expire at the end of each calendar year. Offer subject to change or end without notice. Restrictions, including monthly maximums, may apply. Patients may participate without sharing their income information. See program requirements at INLEXZO.JNJwithMeSavings.com.
The patient support and resources provided by J&J withMe and INLEXZO withMe are not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, provide case management services, or serve as a reason to prescribe INLEXZO™.
Information about your patients' insurance coverage, cost support options, and treatment support is given by service providers for J&J withMe. The information you get does not require you or your patients to use any Johnson & Johnson product. Because the information we give you comes from outside sources, J&J withMe cannot promise the information will be complete.